blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP4359435

EP4359435 - COMBINATION DOSAGE REGIME OF CD137 AND PD-L1 BINDING AGENTS [Right-click to bookmark this link]
StatusRequest for examination was made
Status updated on  29.03.2024
Database last updated on 14.09.2024
FormerThe international publication has been made
Status updated on  30.12.2022
Formerunknown
Status updated on  15.07.2022
Most recent event   Tooltip04.09.2024New entry: Application deemed to be withdrawn: despatch of communication + time limit 
Applicant(s)For all designated states
Genmab A/S
Kalvebod Brygge 43
1560 Copenhagen V / DK
For all designated states
BioNTech SE
An der Goldgrube 12
55131 Mainz / DE
[2024/18]
Inventor(s)01 / SAHIN, Ugur
55116 Mainz / DE
02 / MUIK, Alexander
55131 Mainz / DE
03 / FORSSMANN, Ulf
1560 Copenhagen / DK
04 / JURE-KUNKEL, Maria N.
Plains / US
05 / BAJAJ, Gaurav
Plainsboro, New Jersey 08536 / US
06 / TALHAUSER, Craig
Plainsboro, New Jersey 08536 / US
07 / PENCHEVA, Nora
3584 Utrecht / NL
 [2024/18]
Application number, filing date22735846.220.06.2022
[2024/18]
WO2022EP66764
Priority number, dateUS202163212781P21.06.2021         Original published format: US 202163212781 P
US202163257879P20.10.2021         Original published format: US 202163257879 P
[2024/18]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2022268740
Date:29.12.2022
Language:EN
[2022/52]
Type: A1 Application with search report 
No.:EP4359435
Date:01.05.2024
Language:EN
The application published by WIPO in one of the EPO official languages on 29.12.2022 takes the place of the publication of the European patent application.
[2024/18]
Search report(s)International search report - published on:EP29.12.2022
ClassificationIPC:C07K16/24, C07K16/28, A61K39/00
[2024/18]
CPC:
C07K16/24 (EP,IL); C07K16/2878 (US); A61P35/00 (US);
C07K16/2827 (EP,IL,US); A61K2039/505 (US); A61K2039/54 (US);
A61K2039/545 (EP,IL,US); C07K2317/31 (US); C07K2317/734 (EP,IL) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2024/18]
Extension statesBA22.01.2024
ME22.01.2024
Validation statesKH22.01.2024
MA22.01.2024
MD22.01.2024
TN22.01.2024
TitleGerman:KOMBINATIONSDOSIERUNGSSCHEMA VON CD137- UND PD-L1-BINDENDEN WIRKSTOFFEN[2024/18]
English:COMBINATION DOSAGE REGIME OF CD137 AND PD-L1 BINDING AGENTS[2024/18]
French:RÉGIME POSOLOGIQUE COMBINÉ D'AGENTS DE LIAISON CD137 ET PD-L1[2024/18]
Entry into regional phase22.01.2024National basic fee paid 
22.01.2024Designation fee(s) paid 
22.01.2024Examination fee paid 
Examination procedure22.01.2024Examination requested  [2024/18]
22.01.2024Date on which the examining division has become responsible
03.09.2024Despatch of communication that the application is deemed to be withdrawn, reason: reply to the Extended European Search Report/Written Opinion of the International Searching Authority/International Preliminary Examination Report/Supplementary international search report not received in time
Fees paidRenewal fee
01.07.2024Renewal fee patent year 03
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[XDY]WO2019025545  (GENMAB AS [DK], et al);
by applicantUS201000155133
 WO20100226923
 WO9222653
 EP0629240
 WO9850431
 WO03074569
 WO2005004809
 WO2005035584
 WO2005061547
 WO2007059782
 US7262028
 WO2007110205
 EP1870459
 WO2008003116
 WO2008157379
 WO2009040562
 WO2009058383
 WO2009080254
 WO2009089004
 US7612181
 WO2010015792
 WO2010059315
 WO2010080538
 WO2010111625
 WO2010129304
 WO2010134666
 WO2011028952
 US7951918
 WO2011069104
 WO2011117329
 WO2011131746
 WO2011143545
 CN102250246
 WO2012023053
 WO2012025525
 WO2012025530
 WO2012058768
 WO2013060867
 WO2013157953
 WO2014081202
 WO2015150327
 WO2016110584
 WO2019025545
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.